BR0005189A - Compostos de ciclo-pentanona diidro-piridina úteis como abridores de canais de potássio - Google Patents

Compostos de ciclo-pentanona diidro-piridina úteis como abridores de canais de potássio

Info

Publication number
BR0005189A
BR0005189A BR0005189-6A BR0005189A BR0005189A BR 0005189 A BR0005189 A BR 0005189A BR 0005189 A BR0005189 A BR 0005189A BR 0005189 A BR0005189 A BR 0005189A
Authority
BR
Brazil
Prior art keywords
potassium channel
channel openers
dihydropyridine
compounds useful
cyclopentanone compounds
Prior art date
Application number
BR0005189-6A
Other languages
English (en)
Inventor
William A Carroll
Yiyuan Chen
Irene Drizin
James F Kerwin
Jimmie L Moore
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of BR0005189A publication Critical patent/BR0005189A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C07C45/298—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with manganese derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"COMPOSTOS DE CICLO-PENTANONA DIIDRO-PIRIDINA úTEIS COMO ABRIDORES DE CANAIS DE POTáSSIO" Compostos da fórmula ( I ) são úteis no tratamento de doenças que podem ser prevenidas por abridores de canais de potássio ou melhoradas com eles. Também descritas são composições abridoras de canais de potássio e um processo para se abrir canais de potássio em um mamífero.
BR0005189-6A 1999-03-04 2000-03-06 Compostos de ciclo-pentanona diidro-piridina úteis como abridores de canais de potássio BR0005189A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/262,441 US6518279B2 (en) 1999-03-04 1999-03-04 Cyclopentanone dihydropyridine compounds useful as potassium channel openers
PCT/US2000/005828 WO2000051986A1 (en) 1999-03-04 2000-03-06 Cyclopentanone dihydropyridine compounds useful as potassium channel openers

Publications (1)

Publication Number Publication Date
BR0005189A true BR0005189A (pt) 2001-01-09

Family

ID=22997528

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0005189-6A BR0005189A (pt) 1999-03-04 2000-03-06 Compostos de ciclo-pentanona diidro-piridina úteis como abridores de canais de potássio

Country Status (20)

Country Link
US (1) US6518279B2 (pt)
EP (1) EP1075466A1 (pt)
JP (1) JP2003517454A (pt)
KR (1) KR20010043295A (pt)
CN (1) CN1318053A (pt)
AR (1) AR028987A1 (pt)
AU (1) AU3616800A (pt)
BG (1) BG104999A (pt)
BR (1) BR0005189A (pt)
CA (1) CA2330541A1 (pt)
CO (1) CO5150208A1 (pt)
HU (1) HUP0102895A3 (pt)
IL (1) IL139140A0 (pt)
MX (1) MXPA00010790A (pt)
NO (1) NO20005570L (pt)
PL (1) PL343883A1 (pt)
SK (1) SK18152000A3 (pt)
TR (1) TR200003202T1 (pt)
WO (1) WO2000051986A1 (pt)
ZA (1) ZA200005798B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593335B1 (en) 1997-12-18 2003-07-15 Abbott Laboratories Potassium channel openers
US6265417B1 (en) 1997-12-18 2001-07-24 Abbott Laboratories Potassium channel openers
WO2002010134A1 (en) * 2000-08-02 2002-02-07 Astrazeneca Ab Process for asymmetric synthesis of substituted 1,4-dihydropyridines
US20030045449A1 (en) * 2001-08-15 2003-03-06 Pfizer, Inc. Pharmaceutical combinations for the treatment of neurodegenerative diseases
US20030199578A1 (en) * 2002-04-19 2003-10-23 Turner Sean C. Naphthalene amides as potassium channel openers
EP1994012B1 (en) 2006-02-10 2009-12-09 Janssen Pharmaceutica N.V. Novel tricyclic dihydropyrazines as potassium channel openers
CA2752603C (en) 2009-02-18 2016-04-05 Bayer Pharma Aktiengesellschaft Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof
WO2021253180A1 (en) * 2020-06-15 2021-12-23 Novartis Ag Methyl (r) -2- (fluoromethyl) -5-oxo-4-phenyl-4, 5, 6, 7-tetrahydro-1h-cyclopenta [b] pyridine-3-carboxylate and methyl (r) -2- (fluoromethyl) -5-oxo-4-phenyl-1, 4, 5, 7-tetrahydrofuro [3, 4-b] pyridine-3-carboxylate as cav1.2 activators
US11939316B1 (en) 2023-11-06 2024-03-26 King Faisal University 9-(6-flouro-2-hydroxyouinolin-3-yl)-10-(2-hydroxyethyl)-3,6-diphenyl-3,4,6,7,9,10-hexhydroacridine-1,8(2h,5h)-dione as an antimicrobial compound
US11970478B1 (en) 2023-11-16 2024-04-30 King Faisal University 9-(2-hydroxyquinolin-3-yl)-10-(2-hydroxyethyl)-3,3,6,6-tetramethyl-3,4,6,7,9,10-hexahydroacridine1,8(2H,5H)-dione as an antimicrobial compound

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2003148A1 (de) 1970-01-24 1971-07-29 Bayer Ag Neue 1,4-Dihydropyridinderivate
DE3447170A1 (de) 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen Mischung unterschiedlicher dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
GB8716971D0 (en) 1987-07-17 1987-08-26 Pfizer Ltd Therapeutic agents
GB8907401D0 (en) 1989-04-01 1989-05-17 Pfizer Ltd Therapeutic agents
GB9220570D0 (en) 1991-10-21 1992-11-11 Ici Plc Therapeutic agent
JP3285963B2 (ja) 1991-10-21 2002-05-27 インペリアル・ケミカル・インダストリーズ・ピーエルシー 治療剤
GB9318935D0 (en) 1992-10-20 1993-10-27 Zeneca Ltd Heterocyclic derivatives
DE4313690A1 (de) 1993-04-27 1994-11-03 Bayer Ag Kondensierte Chinolyl-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
EP1040097B1 (en) 1997-12-18 2004-04-14 Abbott Laboratories Potassium channel openers

Also Published As

Publication number Publication date
CN1318053A (zh) 2001-10-17
SK18152000A3 (sk) 2001-06-11
NO20005570D0 (no) 2000-11-03
JP2003517454A (ja) 2003-05-27
US20020007065A1 (en) 2002-01-17
AR028987A1 (es) 2003-06-04
BG104999A (en) 2001-10-31
IL139140A0 (en) 2001-11-25
US6518279B2 (en) 2003-02-11
PL343883A1 (en) 2001-09-10
HUP0102895A3 (en) 2002-01-28
AU3616800A (en) 2000-09-21
CA2330541A1 (en) 2000-09-08
MXPA00010790A (es) 2002-06-04
HUP0102895A2 (hu) 2001-12-28
KR20010043295A (ko) 2001-05-25
NO20005570L (no) 2000-11-03
TR200003202T1 (tr) 2001-08-21
CO5150208A1 (es) 2002-04-29
ZA200005798B (en) 2002-01-18
EP1075466A1 (en) 2001-02-14
WO2000051986A1 (en) 2000-09-08

Similar Documents

Publication Publication Date Title
ATE292133T1 (de) Kaliumkanäleöffner
AU7650294A (en) Aminocyclohexylesters and uses thereof
BR0005189A (pt) Compostos de ciclo-pentanona diidro-piridina úteis como abridores de canais de potássio
PT842934E (pt) Agonistas de 5-ht1f
MXPA04005847A (es) Compuestos derivados de 4-sulfuro/sulfoxido/sulfonil-1h-pirazolilo, para uso en enfermedades asociadas con el receptor 5-ht2c.
BR0209129A (pt) Compostos, composições farmacêuticas, métodos para tratamento de dores, métodos para modulação de uma resposta farmacológica e usos de compostos
BR9916633A (pt) Benzopiranos e benzoxepinas, composições farmacêuticas compreendendo-as e processo de preparação
BR9909468A (pt) Composto anti-bacteriano, composição oral anti-placas, e, processo para promoção da higiene oral
BR9814855A (pt) Processo para tratamento antimicrobiano de microrganismos e/ou vìrus, e, composição antimicrobiana.
BR0312784A (pt) Processo e composição para tratamento de manchas
ATE373642T1 (de) Kalium kanalaktivatoren
BR0115036A (pt) Processo para a preparação de um composto
BR0103913A (pt) Tratamento de combinação para depressão e ansiedade
BR9912556A (pt) Triazolpiridinas para o tratamento de distúrbios trombóticos
BR9813634A (pt) "abridores de canal de potássio"
BR0014626A (pt) Análise de leptina
MXPA03006969A (es) Abridores de canal de potasio.
BR9912138A (pt) Compostos cìclicos úteis no tratamento de dislipidemia, aterosclerose e diabetes, composções farmacêuticas e processo para preparação
ATE188869T1 (de) Stabilisiertes sonnenschutzmittel
IT8620796A1 (it) Processo per la preparazione dell'N-dimetilchitosano e suoi impieghi farmacologici
BR9912817A (pt) Composição terapêutica à base de isoflavonóides destinada a ser utilizada no tratamento dos tumores por agentes citotóxicos
PT1259510E (pt) Agentes de abertura de canais de potassio de di-hidropirazolona triciclina e di-hidro-isoxazolona triciclina
NZ510116A (en) Tricyclic delta-3-piperidines as pharmaceuticals
WO2000024741A3 (en) Dihydropyridine compounds and their use as potassium channel openers
BR9808939A (pt) Composição para tratamento de cabelo para aplicação tópica

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1925 DE 27/11/2007.